The human orthologue of prominin-1, called CD133 has been used as a marker in a variety of cancers to isolate cancer stem cells (CSCs) [1], [2], [3], [4], [5], [6] as well as hematopoietic stem cells [7], [8]. This evidence concerns the gene PROM1 and cancer.